A patient's reaction to infliximab.
Domm
Aaron
A
Department of Internal Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA. aarondomm@yahoo.com
D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D016706:Still's Disease, Adult-Onset / Q000175:diagnosis / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab